Isomorphic Labs
Subsidiary of Alphabet
Subsidiary of Alphabet
Isomorphic Labs Limited is a British multinational artificial intelligence company based in London, England. Isomorphic Labs was founded by Demis Hassabis, who is the CEO, to improve human health by advancing the drug discovery process. The company was incorporated on February 24, 2021 and announced on November 4, 2021. It was established under Alphabet Inc. as a spin-off from its AI research lab DeepMind, which Hassabis co-founded and chairs. Isomorphic Labs was inspired by DeepMind's AlphaFold 2 technology, which predicts a protein's three-dimensional structure from its amino acid sequence with high accuracy. The company has since developed beyond AlphaFold, creating proprietary AI models for drug design across multiple modalities, known as the Isomorphic Labs Drug Design Engine (IsoDDE).
Open boosters, collect cards and trade them. Free to play.
Play for free